glp-1 employer coverage news october 2025 Among the largest employers (with at least 5,000 workers), 43% now cover GLP -1 weight-loss drugs, up from 28% last year. A majority (59%) of those same employers say their cost for the A new Medicare pilot is

At approximately $350 per month ($4,200 per year), which reflects typical injectable maintenance dosing, an individual starting at 240 pounds would lose about 36 pounds over 12 months, translating to roughly $116.67 per pound lost

The market faces growing challenges from counterfeit and compounded GLP-1 products, leading to safety risks and regulatory concerns

Among several strategies for lifestyle intervention, regular exercise is conducive to the transformation of energy utilization, and the energy intake is more inclined to be consumed rather than stored, thus reducing weight regain

Are pregnant or breastfeeding For a complete list of ingredients and safety details, refer to the Contrave medication guide

In this article, we will explore the complex relationship between GLP-1 medications and the thyroid

Deep learning algorithm on H&E whole slide images to characterize TP53 alterations frequency and spatial distribution in breast cancer